Oblimersen in the treatment of metastatic melanoma

ISSN： 1479-6694

Source： Future Oncology, Vol.3, Iss.3, 2007-06, pp. : 263-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutics for the treatment of metastatic melanoma

By Mansfield Aaron S Markovic Svetomir N

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 543-557

Future Medicine

Access to resources Recommend Favorite

Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine

By Seeber A. Binder M. Steiner A. Wolff K. Pehamberger H.

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2129-2131

Elsevier

Access to resources Recommend Favorite

Current and Future Directions in the Treatment of Metastatic Malignant Melanoma

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 6, 2003-11 ,pp. : 393-398

Bentham Science Publishers

Access to resources Recommend Favorite

ASCO 2013—treatment of metastatic melanoma: is it still a story of success?

By Weinlich Georg

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 244-246

Springer Publishing Company

Access to resources Recommend Favorite

Realworld efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1581-1585

Spandidos Publications

Access to resources Recommend Favorite